Upregulation of SPRR3 promotes colorectal tumorigenesis

Molecular Medicine

Volumn 16, Issue 7-8, 2010, Pages 271-277

  Cho, Dong Hyung ^a,b   Jo, Yoon Kyung ^a,b   Roh, Seon Ae ^a,b   Na, Young Soon ^a,b   Kim, Tae Won ^a,b   Jang, Se Jin ^a,b   Kim, Yong Sung ^b,c   Kim, Jin Cheon ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN KINASE B; PROTEIN P53; SMALL PROLINE RICH REPEAT PROTEIN 3; UNCLASSIFIED DRUG; CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN; SPRR3 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GENETICS; CANCER INVASION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UPREGULATION; AGED; BIOSYNTHESIS; CELL TRANSFORMATION; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

AGED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-AKT; UP-REGULATION;

EID: 77954274211     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00187     Document Type: Article

References (37)

1. Shin HR, et al. (2007) National cancer incidence for the year 2002 in Korea. Cancer Res. Treat. 39:139-49.
2. Kinzler KW, Vogelstein B. (1996) Lessons from hereditary colorectal cancer. Cell. 87:159-70.
3. Jass JR. (2006) Colorectal cancer: a multipathway disease. Crit. Rev. Oncog. 12:273-87.
4. Humphries A, Wright NA. (2008) Colonic crypt organization and tumorigenesis. Nat. Rev. Cancer. 8:415-24.
5. Barrier A, et al. (2005) Colon cancer prognosis prediction by gene expression profiling. Oncogene. 24:6155-64.
6. Bianchini M, et al. (2006) Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int. J. Oncol. 29:83-94.
7. Fan J, et al. (2008) Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer. 113:266-75.
8. Kim JC, et al. (2008) Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers. World J. Gastroenterol. 14:6662-72.
9. Tesfaigzi J, Th'ng J, Hotchkiss JA, Harkema JR, Wright PS. (1996) A small proline-rich protein, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelia. Am. J. Respir. Cell Mol. Biol. 14:478-86.
10. Pradervand S, et al. (2004) Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein. EMBO J. 23:4517-25.
11. Bracken S, Byrne G, Kelly J, Jackson J, Feighery C. (2008) Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics. 9:377-90.
12. Pyle AL, et al. (2009) Biomechanical stress induces novel arterial intima-enriched genes: implications for vascular adaptation to stress. Cardiovasc. Pathol. 2010;19:e13-20.
13. Abraham JM, et al. (1996) Esophagin cDNA cloning and characterization: a tissue-specific member of the small proline-rich protein family that is not expressed in esophageal tumors. Cell Growth Differ. 7:855-60.
14. Chen BS, et al. (2000) Decreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis. 21:2147-50.
15. Zhang Y, et al. (2008) Exogenous expression of Esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis. Int. J. Cancer. 122:260-6.
16. Franke TF. (2008) PI3K/Akt: getting it right matters. Oncogene. 27:6473-88.
17. Zhou BP, et al. (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3:973-82.
18. Ogawara Y, et al. (2002) Akt enhances Mdm2- mediated ubiquitination and degradation of p53. J. Biol. Chem. 277:21843-50.
19. Mayo LD, Donner DB. (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U. S. A. 98:11598-603.
20. Kim JC, et al. (1996) Establishment and biological characterization of human colorectal carcinoma cell lines expressing carcinoembryonic antigen. J. Korean Cancer Assoc. 28:63-71.
21. Kimchi ET, et al. (2005) Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation Cancer Res. 65:3146-54.
22. Zlobec I, Lugli A. (2008) Prognostic and predictive factors in colorectal cancer. J. Clin. Pathol. 61:561-9.
23. Lim SB, et al. (2009) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis. Colon Rectum. 53:377-84.
24. Dong X, Seelan RS, Qian C, Mai M, Liu W. (2001) Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene. Cytogenet. Cell Genet. 93:26-8.
25. He TC, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science. 281:1509-12.
26. Araki Y, et al. (2003) Regulation of cyclooxyge-nase-2 expression by the Wnt and ras pathways. Cancer Res. 63:728-34.
27. Shitashige M, Hirohashi S, Yamada T. (2008) Wnt signaling inside the nucleus. Cancer Sci. 99:631-7.
28. Testa JR, Bellacosa A. (2001) AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 98:10983-5.
29. McCubrey JA, et al. (2006) Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv. Enzyme Regul. 46:49-79.
30. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785-9.
31. Zhou BP, et al. (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245-52.
32. Liang J, Slingerland JM. (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2:339-45.
33. Pyle AL, et al. (2008) Regulation of the atheromaenriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction. Am. J. Pathol. 173:1577-88.
34. Troussard AA, et al. (2006) Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res. 66:393-403.
35. Loufrani L, et al. (2008) Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 294:H1906-13.
36. Vazquez A, Bond EE, Levine AJ, Bond GL. (2008) The genetics of the p53 pathway, apoptosis and cancer therapy. Nat. Rev. Drug Discov. 7:979-87.
37. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 26:2157-65.